Gala vs Novi: Which GLP-1 Provider Is Better?
Short answer: Novi scores higher on our rubric, 7.8/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Novi beats Gala overall, scoring 7.8/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Novi is from $88/mo. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepatide at a low monthly rate and can accept a three-month commitment charged upfront.
A side-by-side look at Gala and Novi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#30 of 54Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.
Visit GalaNovi
#8 of 54Telehealth platform for compounded semaglutide and tirzepatide that also lists brand-name Mounjaro, Ozempic, Wegovy and Zepbound in stock from $1500. Pricing is published per billing cycle on the product pages: compounded semaglutide at $149 for one month, $130 for three, $129 for six and $88 for twelve; compounded tirzepatide at $179, $149, $133 and $129 across the same cycles. The monthly price covers the consultation, medication, supplies, shipping and unlimited physician messaging, and it does not change with the dose. The homepage advertises "Cancel anytime", but the terms of service require a minimum three-month commitment charged upfront and called non-refundable.
Visit Novi| Feature | Gala | Novi |
|---|---|---|
| Why each one | A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling. | One of the cheapest published compounded rates in the category, $88/mo for semaglutide and $129/mo for tirzepatide on a twelve-month cycle, on a site that also stocks brand-name Mounjaro, Ozempic, Wegovy and Zepbound from $1500. The price is real. So is the three-month commitment charged upfront that the homepage does not mention. |
| Our Score | 7.2/10 | 7.8/10 |
| Headline Price | from $149/mo | from $88/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging | Cash-pay patients who want compounded semaglutide or tirzepatide at a low monthly rate and can accept a three-month commitment charged upfront |
| Watch out for | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line. | The homepage advertises "Cancel anytime" and "No monthly membership", but the terms of service require a minimum three-month commitment with all three months charged at purchase and called non-refundable |
| Ranking | #30 | #8 |
| Get started | Visit Gala | Visit Novi |
Pros & Cons Compared
Gala
Pros
- +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
- +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
- −Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Novi
Pros
- +Compounded and brand-name GLP-1s in one catalogue: compounded semaglutide and tirzepatide with published rates, plus Mounjaro, Ozempic, Wegovy and Zepbound listed in stock from $1500
- +Serves all 50 states and Washington DC, with a short video or audio visit required only in Kansas, Louisiana, Mississippi, New Mexico and West Virginia
- +Per cycle prices are printed on the product pages instead of hidden behind the quiz: compounded semaglutide at $149 for one month, $130 for three, $129 for six and $88 for twelve
- +Unlimited physician messaging, follow-ups and dose adjustments through the online portal, with consultation, supplies and shipping included in the monthly price and the same price at every dose
- +Free 2-day shipping; Novi markets compounded semaglutide and tirzepatide, which are not FDA-approved brands or generics and are not established as equivalent to Wegovy, Ozempic, Mounjaro, or Zepbound
- +On-time refills shipped every 28 days after a short check-in, with free discreet delivery quoted at two to three business days on the product pages
Cons
- −The homepage advertises "Cancel anytime" and "No monthly membership", but the terms of service require a minimum three-month commitment with all three months charged at purchase and called non-refundable
- −The only address Novi shows is a Sheridan, Wyoming mailing suite used by large numbers of registered LLCs, the terms name Novi International LLC in one place and Novi Health LLC in the arbitration clause, and no founding year is shown on its terms, privacy or FAQ pages (rendered check 2026-09-03)
- −The cheapest advertised rates need the longest billing cycle: compounded semaglutide is $88/mo on the twelve-month cycle but $149/mo on the one-month cycle, and compounded tirzepatide runs $129/mo to $179/mo the same way
- −The refund policy says Novi is "unable to accept returns", while the product pages advertise a Progress Promise full refund and point to the terms of service for the details; "Progress Promise" is not shown anywhere on that terms page (rendered check 2026-09-03)
- −Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
- −The headline price on the homepage changes with screen width, $133/mo on a desktop and $99/mo on a phone at the same address, and it sits beside a countdown that restarts on every page load
Our Verdict
Novi edges out Gala with a score of 7.8/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Novi is from $88/mo.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Gala and Novi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Gala and Ivim Healthfrom $150/mo
- Compare Gala and Mochi Healthfrom $139/mo
- Compare Gala and Elevate Healthfrom $158/mo
- Compare Novi and SynergyRxfrom $199/mo
- Compare Novi and Wellorithmfrom $147/mo
- Compare Novi and SnagRxpublished $99/mo; total not verified
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Gala legit, with the verification evidence behind each answer.
Our pick of these two: Novi · 7.8/10